跳至主要内容
临床试验/ACTRN12620000868987
ACTRN12620000868987尚未招募2 期

Assessment of the effect of a novel curcumin formulation on markers of inflammation and oxidative damage in healthy middle age participants

Australasian Research Institute0 个研究点目标入组 45 人开始时间: 2020年8月31日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 60 Years(—)
性别
All

入选标准

  • Participants recruited into this study will be males and/or females aged between 40 and 60 years who:
  • are not currently taking any pharmacotherapies for inflammatory disorders including, rheumatoid arthritis and other autoimmune conditions including, Lupus, MS, Guillian-Barre syndrome, psoriasis etc.
  • do not have impaired renal function,
  • do not regularly take aspirin, ibuprofen or other anti-inflammatory medications,
  • are willing to cease supplementation(e.g. antioxidants, flavonoids, minerals, omega-3 etc) for at least 7 days before the start of this study, and are willing to refrain from taking additional supplements for the duration of the trial,
  • have no known sensitivity to turmeric, curcumin or its metabolites, or red/yellow food colouring,
  • have an hsCRP between 2.5 – 10.00 µg/mL,
  • are not pregnant

排除标准

  • - Are currently taking anti-inflammatory medication
  • - Are cognitively impaired and/or are unable to give informed consent for any reason

研究者

发起方
Australasian Research Institute

相似试验